Fig. 1 · Structure
Documents & Downloads
(Rac)-Emtricitabine S-oxide
Emtricitabine Degradant
(Rac)-Emtricitabine S-oxide is a racemic modification of Emtricitabine S-oxide, recognized as a significant degradation product of Emtricitabine. As a nucleoside reverse transcriptase inhibitor, Emtricitabine is widely utilized in HIV infection therapy. This degradation product is crucial for understanding the stability and metabolic pathways of Emtricitabine in chemical research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2733287-29-9 |
| Applications | Emtricitabine Degradant |
| Formula | C8H10FN3O4S |
| Molecular Weight | 263.25 |
| Synonyms | (Rac)-Emtricitabine sulfoxide; (Rac)-Emtricitabine Degradant-III |
| SMILES | O=C1N=C(N)C(F)=CN1C(OC2CO)CS2=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.